Sylvia Villeneuve, Ph.D. - Publications

Affiliations: 
2011 Université de Montréal, Montréal, Canada 

100 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Wearn A, Tremblay SA, Tardif CL, Leppert IR, Gauthier CJ, Baracchini G, Hughes C, Hewan P, Tremblay-Mercier J, Rosa-Neto P, Poirier J, Villeneuve S, Schmitz TW, Turner GR, Spreng RN. Neuromodulatory subcortical nucleus integrity is associated with white matter microstructure, tauopathy and APOE status. Nature Communications. 15: 4706. PMID 38830849 DOI: 10.1038/s41467-024-48490-z  0.355
2024 Yakoub Y, Gonzalez-Ortiz F, Ashton NJ, Déry C, Strikwerda-Brown C, St-Onge F, Ourry V, Schöll M, Geddes MR, Ducharme S, Montembeault M, Rosa-Neto P, Soucy JP, Breitner JCS, Zetterberg H, ... ... Villeneuve S, et al. Plasma p-tau217 predicts cognitive impairments up to ten years before onset in normal older adults. Medrxiv : the Preprint Server For Health Sciences. PMID 38766113 DOI: 10.1101/2024.05.09.24307120  0.65
2024 Wiesman AI, Gallego-Rudolf J, Villeneuve S, Baillet S, Wilson TW. Alignments between cortical neurochemical systems, proteinopathy and neurophysiological alterations along the Alzheimer's disease continuum. Medrxiv : the Preprint Server For Health Sciences. PMID 38645027 DOI: 10.1101/2024.04.13.24305551  0.325
2024 Qiu T, Liu ZQ, Rheault F, Legarreta JH, Valcourt Caron A, St-Onge F, Strikwerda-Brown C, Metz A, Dadar M, Soucy JP, Pichet Binette A, Spreng RN, Descoteaux M, Villeneuve S. Structural white matter properties and cognitive resilience to tau pathology. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 38561254 DOI: 10.1002/alz.13776  0.394
2024 St-Onge F, Chapleau M, Breitner JCS, Villeneuve S, Pichet Binette A. Tau accumulation and its spatial progression across the Alzheimer's disease spectrum. Brain Communications. 6: fcae031. PMID 38410618 DOI: 10.1093/braincomms/fcae031  0.459
2023 Quesnel MJ, Labonté A, Picard C, Zetterberg H, Blennow K, Brinkmalm A, Villeneuve S, Poirier J. Insulin-like growth factor binding protein-2 in at-risk adults and autopsy-confirmed Alzheimer brains. Brain : a Journal of Neurology. PMID 37992295 DOI: 10.1093/brain/awad398  0.324
2023 Samson AD, Rajagopal S, Pasvanis S, Villeneuve S, McIntosh AR, Rajah MN. Sex differences in longitudinal changes of episodic memory-related brain activity and cognition in cognitively unimpaired older adults with a family history of Alzheimer's disease. Neuroimage. Clinical. 40: 103532. PMID 37931333 DOI: 10.1016/j.nicl.2023.103532  0.337
2023 Ourry V, Binette AP, St-Onge F, Strikwerda-Brown C, Chagnot A, Poirier J, Breitner J, Arenaza-Urquijo EM, Rabin JS, Buckley R, Gonneaud J, Marchant NL, Villeneuve S. How do modifiable risk factors affect Alzheimer's disease pathology or mitigate its effect on clinical symptom expression? Biological Psychiatry. PMID 37689129 DOI: 10.1016/j.biopsych.2023.09.003  0.366
2023 St-Onge F, Chapleau M, Breitner JC, Villeneuve S, Binette AP. Tau accumulation and its spatial progression across the Alzheimer's disease spectrum. Medrxiv : the Preprint Server For Health Sciences. PMID 37333413 DOI: 10.1101/2023.06.02.23290880  0.424
2023 Yakoub Y, Ashton NJ, Strikwerda-Brown C, Montoliu-Gaya L, Karikari TK, Kac PR, Gonzalez-Ortiz F, Gallego-Rudolf J, Meyer PF, St-Onge F, Schöll M, Soucy JP, Breitner JCS, Zetterberg H, Blennow K, ... ... Villeneuve S, et al. Longitudinal blood biomarker trajectories in preclinical Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 37294682 DOI: 10.1002/alz.13318  0.597
2023 Veréb D, Mijalkov M, Chang YW, Canal-Garcia A, Gomez-Ruis E, Maass A, Villeneuve S, Volpe G, Pereira JB. Functional gradients of the medial parietal cortex in a healthy cohort with family history of sporadic Alzheimer's disease. Alzheimer's Research & Therapy. 15: 82. PMID 37076873 DOI: 10.1186/s13195-023-01228-3  0.656
2023 Wood ME, Xiong LY, Wong YY, Buckley RF, Swardfager W, Masellis M, Lim ASP, Nichols E, Joie R, Casaletto KB, Kumar RG, Dams-O'Connor K, Palta P, George KM, Satizabal CL, ... ... Villeneuve S, et al. Sex differences in associations between APOE ε2 and longitudinal cognitive decline. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 36994910 DOI: 10.1002/alz.13036  0.359
2023 Intzandt B, Sanami S, Huck J, Villeneuve S, Bherer L, Gauthier CJ. Sex-specific relationships between obesity, physical activity, and gray and white matter volume in cognitively unimpaired older adults. Geroscience. PMID 36781598 DOI: 10.1007/s11357-023-00734-4  0.453
2022 Strikwerda-Brown C, Ozlen H, Pichet Binette A, Chapleau M, Marchant NL, Breitner JCS, Villeneuve S. Trait Mindfulness Is Associated With Less Amyloid, Tau, and Cognitive Decline in Individuals at Risk for Alzheimer's Disease. Biological Psychiatry Global Open Science. 3: 130-138. PMID 36712573 DOI: 10.1016/j.bpsgos.2022.01.001  0.74
2022 Morrison C, Dadar M, Villeneuve S, Ducharme S, Collins DL. White matter hyperintensity load varies depending on subjective cognitive decline criteria. Geroscience. PMID 36401741 DOI: 10.1007/s11357-022-00684-3  0.407
2022 Strikwerda-Brown C, Hobbs DA, Gonneaud J, St-Onge F, Binette AP, Ozlen H, Provost K, Soucy JP, Buckley RF, Benzinger TLS, Morris JC, Villemagne VL, Doré V, Sperling RA, Johnson KA, ... ... Villeneuve S, et al. Association of Elevated Amyloid and Tau Positron Emission Tomography Signal With Near-Term Development of Alzheimer Disease Symptoms in Older Adults Without Cognitive Impairment. Jama Neurology. PMID 35907254 DOI: 10.1001/jamaneurol.2022.2379  0.433
2022 Morrison C, Dadar M, Villeneuve S, Collins DL. White matter lesions may be an early marker for age-related cognitive decline. Neuroimage. Clinical. 35: 103096. PMID 35764028 DOI: 10.1016/j.nicl.2022.103096  0.405
2022 Groot C, Villeneuve S, Smith R, Hansson O, Ossenkoppele R. Tau PET Imaging in Neurodegenerative Disorders. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 63: 20S-26S. PMID 35649647 DOI: 10.2967/jnumed.121.263196  0.388
2022 Jansen WJ, Janssen O, Tijms BM, Vos SJB, Ossenkoppele R, Visser PJ, Aarsland D, Alcolea D, Altomare D, von Arnim C, Baiardi S, Baldeiras I, Barthel H, Bateman RJ, ... ... Villeneuve S, et al. Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum. Jama Neurology. PMID 35099509 DOI: 10.1001/jamaneurol.2021.5216  0.641
2022 Meyer PF, Ashton NJ, Karikari TK, Strikwerda-Brown C, Köbe T, Gonneaud J, Pichet Binette A, Ozlen H, Yakoub Y, Simrén J, Pannee J, Lantero-Rodriguez J, Labonté A, Baker SL, Schöll M, ... ... Villeneuve S, et al. Plasma p-tau231, p-tau181, PET biomarkers and cognitive change in older adults. Annals of Neurology. PMID 35084051 DOI: 10.1002/ana.26308  0.641
2021 Morrison C, Dadar M, Shafiee N, Villeneuve S, Louis Collins D. Regional brain atrophy and cognitive decline depend on definition of subjective cognitive decline. Neuroimage. Clinical. 33: 102923. PMID 34959049 DOI: 10.1016/j.nicl.2021.102923  0.447
2021 Janssen O, Jansen WJ, Vos SJB, Boada M, Parnetti L, Gabryelewicz T, Fladby T, Molinuevo JL, Villeneuve S, Hort J, Epelbaum S, Lleó A, Engelborghs S, van der Flier WM, Landau S, et al. Characteristics of subjective cognitive decline associated with amyloid positivity. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 34877782 DOI: 10.1002/alz.12512  0.632
2021 Nilsson NIV, Picard C, Labonté A, Köbe T, Meyer PF, Villeneuve S, Auld D, Poirier J, For The Prevent-Ad Research Group, Alzheimer's Disease Neuroimaging Initiative. Association of a Total Cholesterol Polygenic Score with Cholesterol Levels and Pathological Biomarkers across the Alzheimer's Disease Spectrum. Genes. 12. PMID 34828411 DOI: 10.3390/genes12111805  0.354
2021 Picard C, Nilsson N, Labonté A, Auld D, Rosa-Neto P, Ashton NJ, Zetterberg H, Blennow K, Breitner JCB, Villeneuve S, Poirier J. Apolipoprotein B is a novel marker for early tau pathology in Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 34590423 DOI: 10.1002/alz.12442  0.356
2021 Gonneaud J, Baria AT, Pichet Binette A, Gordon BA, Chhatwal JP, Cruchaga C, Jucker M, Levin J, Salloway S, Farlow M, Gauthier S, Benzinger TLS, Morris JC, Bateman RJ, Breitner JCS, ... ... Villeneuve S, et al. Accelerated functional brain aging in pre-clinical familial Alzheimer's disease. Nature Communications. 12: 5346. PMID 34504080 DOI: 10.1038/s41467-021-25492-9  0.364
2021 Tremblay-Mercier J, Madjar C, Das S, Pichet Binette A, Dyke SOM, Étienne P, Lafaille-Magnan ME, Remz J, Bellec P, Louis Collins D, Natasha Rajah M, Bohbot V, Leoutsakos JM, Iturria-Medina Y, Kat J, ... ... Villeneuve S, et al. Open science datasets from PREVENT-AD, a longitudinal cohort of pre-symptomatic Alzheimer's disease. Neuroimage. Clinical. 31: 102733. PMID 34192666 DOI: 10.1016/j.nicl.2021.102733  0.336
2021 Pichet Binette A, Theaud G, Rheault F, Roy M, Collins DL, Levin J, Mori H, Lee JH, Farlow MR, Schofield P, Chhatwal JP, Masters CL, Benzinger T, Morris J, Bateman R, ... ... Villeneuve S, et al. Bundle-specific associations between white matter microstructure and Aβ and tau pathology in preclinical Alzheimer's disease. Elife. 10. PMID 33983116 DOI: 10.7554/eLife.62929  0.374
2021 Köbe T, Binette AP, Vogel JW, Meyer PF, Breitner JCS, Poirier J, Villeneuve S. Vascular risk factors are associated with a decline in resting-state functional connectivity in cognitively unimpaired individuals at risk for Alzheimer's disease: Vascular risk factors and functional connectivity changes. Neuroimage. 117832. PMID 33549747 DOI: 10.1016/j.neuroimage.2021.117832  0.334
2020 Ossenkoppele R, Leuzy A, Cho H, Sudre CH, Strandberg O, Smith R, Palmqvist S, Mattsson-Carlgren N, Olsson T, Jögi J, Stormrud E, Ryu YH, Choi JY, ... ... Villeneuve S, et al. The impact of demographic, clinical, genetic, and imaging variables on tau PET status. European Journal of Nuclear Medicine and Molecular Imaging. PMID 33215319 DOI: 10.1007/s00259-020-05099-w  0.392
2020 Gonneaud J, Bedetti C, Binette AP, Benzinger TLS, Morris JC, Bateman RJ, Poirier J, Breitner JCS, Villeneuve S. Association of education with Aβ burden in preclinicial familial and sporadic Alzheimer disease. Neurology. PMID 32759192 DOI: 10.1212/Wnl.0000000000010314  0.403
2020 Han JW, Maillard P, Harvey D, Fletcher E, Martinez O, Johnson DK, Olichney JM, Farias ST, Villeneuve S, Jagust W, Mungas D, DeCarli C. Association of vascular brain injury, neurodegeneration, amyloid and cognitive trajectory. Neurology. PMID 32732300 DOI: 10.1212/Wnl.0000000000010531  0.644
2020 Marchant NL, Lovland LR, Jones R, Pichet Binette A, Gonneaud J, Arenaza-Urquijo EM, Chételat G, Villeneuve S. Repetitive negative thinking is associated with amyloid, tau, and cognitive decline. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 32508019 DOI: 10.1002/Alz.12116  0.744
2020 Pichet Binette A, Vachon-Presseau É, Morris J, Bateman R, Benzinger T, Collins DL, Poirier J, Breitner JCS, Villeneuve S. Amyloid and Tau Pathology Associations With Personality Traits, Neuropsychiatric Symptoms, and Cognitive Lifestyle in the Preclinical Phases of Sporadic and Autosomal Dominant Alzheimer's Disease. Biological Psychiatry. PMID 32228870 DOI: 10.1016/J.Biopsych.2020.01.023  0.542
2020 Pichet Binette A, Gonneaud J, Vogel JW, La Joie R, Rosa-Neto P, Collins DL, Poirier J, Breitner JCS, Villeneuve S, Vachon-Presseau E. Morphometric network differences in ageing versus Alzheimer's disease dementia. Brain : a Journal of Neurology. 143: 635-649. PMID 32040564 DOI: 10.1093/Brain/Awz414  0.474
2020 Köbe T, Gonneaud J, Pichet Binette A, Meyer PF, McSweeney M, Rosa-Neto P, Breitner JCS, Poirier J, Villeneuve S. Association of Vascular Risk Factors With β-Amyloid Peptide and Tau Burdens in Cognitively Unimpaired Individuals and Its Interaction With Vascular Medication Use. Jama Network Open. 3: e1920780. PMID 32031648 DOI: 10.1001/jamanetworkopen.2019.20780  0.337
2020 McSweeney M, Pichet Binette A, Meyer PF, Gonneaud J, Bedetti C, Ozlen H, Labonté A, Rosa-Neto P, Breitner J, Poirier J, Villeneuve S. Intermediate flortaucipir uptake is associated with Aβ-PET and CSF-tau in asymptomatic adults. Neurology. PMID 32015176 DOI: 10.1212/Wnl.0000000000008905  0.448
2020 Meyer PF, Binette AP, Gonneaud J, Breitner JCS, Villeneuve S. Characterization of Alzheimer Disease Biomarker Discrepancies Using Cerebrospinal Fluid Phosphorylated Tau and AV1451 Positron Emission Tomography. Jama Neurology. PMID 31961372 DOI: 10.1001/Jamaneurol.2019.4749  0.396
2019 Villeneuve S. Lifespan Cognitive Reserve-A Secret to Coping With Neurodegenerative Pathology. Jama Neurology. 76: 1145-1146. PMID 31609408 DOI: 10.1001/Jamaneurol.2019.2899  0.466
2019 Meyer PF, McSweeney M, Gonneaud J, Villeneuve S. AD molecular: PET amyloid imaging across the Alzheimer's disease spectrum: From disease mechanisms to prevention. Progress in Molecular Biology and Translational Science. 165: 63-106. PMID 31481172 DOI: 10.1016/Bs.Pmbts.2019.05.001  0.438
2019 DeCarli C, Villeneuve S, Maillard P, Harvey D, Singh B, Carmichael O, Fletcher E, Olichney J, Farias S, Jagust W, Reed B, Mungas D. Vascular Burden Score Impacts Cognition Independent of Amyloid PET and MRI Measures of Alzheimer's Disease and Vascular Brain Injury. Journal of Alzheimer's Disease : Jad. PMID 30775991 DOI: 10.3233/Jad-180965  0.613
2019 Gonneaud J, Baria A, Binette AP, Benzinger TLS, Morris JC, Bateman R, Breitner JCS, Poirier J, Vachon-Presseau E, Villeneuve S. Ic-P-054: Prediction Of Brain Age Using Resting-State Functional Connectivity Reveals Accelerated Aging In The Preclinical Phase Of Autosomal Dominant Alzheimer'S Disease, Irrespectiveof Amyloid Pathology Alzheimers & Dementia. 15: 240. DOI: 10.1016/J.Jalz.2019.06.4897  0.384
2019 Meyer P, Binette AP, Breitner JCS, Villeneuve S, Initiative ADN. O4-12-04: Cerebrospinal Fluid And Pet Measures Of Tau Pathology Indicate A Different State Of Ad Pathophysiological Progression Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.4809  0.359
2019 Binette AP, Gonneaud J, Villeneuve S, Initiative ADN. Ic-P-174: Flortaucipir Deposition Pattern Across The Alzheimer'S Disease Spectrum: Characterization At The Individual Level Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.3957  0.335
2019 Köbe T, Gonneaud J, Binette AP, Meyer P, McSweeney M, Rosa-Neto P, Breitner JC, Poirier J, Villeneuve S. P1-431: VASCULAR MEDICAL TREATMENTS INFLUENCE THE ASSOCIATION BETWEEN VASCULAR BURDEN AND AMYLOID PATHOLOGY IN ASYMPTOMATIC INDIVIDUALS AT RISK FOR ALZHEIMER'S DISEASE Alzheimer's & Dementia. 15: P430-P430. DOI: 10.1016/J.Jalz.2019.06.1036  0.397
2018 Vogel JW, Mattsson N, Iturria-Medina Y, Strandberg OT, Schöll M, Dansereau C, Villeneuve S, van der Flier WM, Scheltens P, Bellec P, Evans AC, Hansson O, Ossenkoppele R. Data-driven approaches for tau-PET imaging biomarkers in Alzheimer's disease. Human Brain Mapping. PMID 30368979 DOI: 10.1002/Hbm.24401  0.649
2018 Verfaillie SCJ, Pichet Binette A, Vachon-Presseau E, Tabrizi S, Savard M, Bellec P, Ossenkoppele R, Scheltens P, van der Flier WM, Breitner JCS, Villeneuve S. Subjective Cognitive Decline Is Associated With Altered Default Mode Network Connectivity in Individuals With a Family History of Alzheimer's Disease. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. 3: 463-472. PMID 29735156 DOI: 10.1016/J.Bpsc.2017.11.012  0.503
2018 Vogel JW, Vachon-Presseau E, Pichet Binette A, Tam A, Orban P, La Joie R, Savard M, Picard C, Poirier J, Bellec P, Breitner JCS, Villeneuve S. Brain properties predict proximity to symptom onset in sporadic Alzheimer's disease. Brain : a Journal of Neurology. PMID 29688388 DOI: 10.1093/Brain/Awy093  0.42
2018 Villeneuve S, Vogel JW, Gonneaud J, Pichet Binette A, Rosa-Neto P, Gauthier S, Bateman RJ, Fagan AM, Morris JC, Benzinger TLS, Johnson SC, Breitner JCS, Poirier J. Proximity to Parental Symptom Onset and Amyloid-β Burden in Sporadic Alzheimer Disease. Jama Neurology. PMID 29482212 DOI: 10.1001/Jamaneurol.2017.5135  0.381
2018 Binette AP, Vachon-Presseau E, Gonneaud J, Marchant NL, Bellec P, Breitner JCS, Villeneuve S. F5-05-02: Neuropsychiatric Burden Is Related To Increased Amyloid But Not Tau Deposition In Cognitively Normal Older Adults Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2985  0.451
2018 Gonneaud J, Bedetti C, Binette AP, Benzinger TLS, Morris JC, Bateman RJ, Poirier J, Breitner JCS, Villeneuve S. IC-P-158: GENETIC AND ENVIRONMENTAL FACTORS ARE DIFFERENTIALLY RELATED TO Aβ BURDEN IN THE PRESYMPTOMATIC PHASE OF AUTOSOMAL DOMINANT AND SPORADIC ALZHEIMER'S DISEASE Alzheimers & Dementia. 14: 134. DOI: 10.1016/J.Jalz.2018.06.2225  0.346
2018 Binette AP, Vachon-Presseau E, Gonneaud J, Marchant NL, Bellec P, Breitner JCS, Villeneuve S. Ic-P-148: Neuropsychiatric Burden Is Related To Increased Amyloid But Not Tau Deposition In Late Middle-Aged Cognitively Normal Individuals With A Family History Of Alzheimer'S Disease Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2214  0.485
2017 Mander BA, Zhu AH, Lindquist JR, Villeneuve S, Rao V, Lu B, Saletin JM, Ancoli-Israel S, Jagust W, Walker MP. White matter structure in older adults moderates the benefit of sleep spindles on motor memory consolidation. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 29084867 DOI: 10.1523/Jneurosci.3033-16.2017  0.434
2017 Grothe MJ, Villeneuve S, Dyrba M, Bartrés-Faz D, Wirth M. Multimodal characterization of older APOE2 carriers reveals selective reduction of amyloid load. Neurology. PMID 28062720 DOI: 10.1212/Wnl.0000000000003585  0.327
2017 Seo SW, Ayakta N, Grinberg LT, Villeneuve S, Lehmann M, Reed B, DeCarli C, Miller BL, Rosen HJ, Boxer AL, O'Neil JP, Jin LW, Seeley WW, Jagust WJ, Rabinovici GD. Regional correlations between [(11)C]PIB PET and post-mortem burden of amyloid-beta pathology in a diverse neuropathological cohort. Neuroimage. Clinical. 13: 130-137. PMID 27981028 DOI: 10.1016/J.Nicl.2016.11.008  0.515
2017 Vogel JW, Mattsson N, Medina YI, Strandberg O, Schöll M, Dansereau C, Villeneuve S, Flier WMvd, Scheltens P, Bellec P, Evans AC, Hansson O, Ossenkoppele R. Data-Driven Tau-Pet Covariance Networks Enhance Prediction Of Retrospective Cognitive Change In Alzheimer’S Disease Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.07.687  0.647
2017 Verfaillie SC, Binette AP, Vachon-Presseau É, Tabrizi S, Savard M, Bellec P, Ossenkoppele R, Scheltens P, van der Flier WM, Breitner JC, Villeneuve S. [IC-P-037]: SUBJECTIVE COGNITIVE DECLINE IS ASSOCIATED WITH ALTERED POSTERIOR CINGULATE CONNECTIVITY IN ELDERLY WITH A FAMILIAL HISTORY OF ALZHEIMER's DISEASE Alzheimer's & Dementia. 13: P33-P34. DOI: 10.1016/j.jalz.2017.06.2309  0.36
2017 Verfaillie SC, Binette AP, Vachon-Presseau É, Tabrizi S, Savard M, Bellec P, Ossenkoppele R, Scheltens P, van der Flier WM, Breitner JC, Villeneuve S. [P3-407]: SUBJECTIVE COGNITIVE DECLINE IS ASSOCIATED WITH ALTERED POSTERIOR CINGULATE CONNECTIVITY IN ELDERLY WITH A FAMILIAL HISTORY OF ALZHEIMER's DISEASE Alzheimer's & Dementia. 13: P1120-P1121. DOI: 10.1016/J.Jalz.2017.06.1624  0.479
2017 Binette AP, Vachon-Presseau É, Joie RL, Poirier J, Rosa-Neto P, Collins L, Breitner JCS, Villeneuve S. Moving Away From Single Ad-Signature Roi: Assessing The Relationship Between Whole-Brain Gray Matter Pattern, Ad Pathology, And Cognition In Healthy Elderly At Risk Of Ad Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.06.1579  0.496
2016 Villeneuve S. Cause of Suspected Non-Alzheimer Disease Pathophysiology: If Not Tau Pathology, Then What? Jama Neurology. PMID 27548079 DOI: 10.1001/Jamaneurol.2016.2842  0.399
2016 Fletcher E, Villeneuve S, Maillard P, Harvey D, Reed B, Jagust W, DeCarli C. β-amyloid, hippocampal atrophy and their relation to longitudinal brain change in cognitively normal individuals. Neurobiology of Aging. 40: 173-80. PMID 26973117 DOI: 10.1016/J.Neurobiolaging.2016.01.133  0.609
2016 Binette AP, Vogel JW, Fonov VS, Madjar C, Tremblay-Mercier J, Breitner JCS, Collins L, Poirier J, Villeneuve S. High Csf Tau Is Related To Reduced Hippocampal Volume And Subjective Cognitive Decline In Healthy Elderly With Amyloid Pathology Alzheimers & Dementia. 12. DOI: 10.1016/J.Jalz.2016.06.168  0.489
2016 Grothe MJ, Villeneuve S, Dyrba M, Bartrés-Faz D, Wirth M. IC-P-008: Multimodal Imaging of Apoe2 Effects in The Aged Brain: Specificity for Reduced Amyloid Pathology Alzheimer's & Dementia. 12: P17-P18. DOI: 10.1016/J.Jalz.2016.06.018  0.327
2015 Villeneuve S, Rabinovici GD, Cohn-Sheehy BI, Madison C, Ayakta N, Ghosh PM, La Joie R, Arthur-Bentil SK, Vogel JW, Marks SM, Lehmann M, Rosen HJ, Reed B, Olichney J, Boxer AL, et al. Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation. Brain : a Journal of Neurology. 138: 2020-33. PMID 25953778 DOI: 10.1093/Brain/Awv112  0.497
2015 Villeneuve S, Wirth M, La Joie R. Are AD-Typical Regions the Convergence Point of Multiple Pathologies? Frontiers in Aging Neuroscience. 7: 42. PMID 25859215 DOI: 10.3389/Fnagi.2015.00042  0.482
2015 Villeneuve S, Jagust WJ. Imaging Vascular Disease and Amyloid in the Aging Brain: Implications for Treatment. The Journal of Prevention of Alzheimer's Disease. 2: 64-70. PMID 25844350 DOI: 10.14283/jpad.2015.47  0.48
2015 Villeneuve S, St. Amant H, Vogel JW, Marks S, Wirth M, DeCarli C, Jagust WJ. P3-145: Are low levels of PiB-PET signal clinically significant? Alzheimer's & Dementia. 11: P681-P682. DOI: 10.1016/J.Jalz.2015.06.1013  0.343
2015 Villeneuve S, Amant HS, Vogel JW, Marks S, Wirth M, DeCarli C, Jagust WJ. IC-01-01: Are low levels of PiB-PET signal clinically significant? Alzheimer's & Dementia. 11: P1-P1. DOI: 10.1016/J.Jalz.2015.06.002  0.332
2014 Villeneuve S, Brisson D, Marchant NL, Gaudet D. The potential applications of Apolipoprotein E in personalized medicine. Frontiers in Aging Neuroscience. 6: 154. PMID 25071563 DOI: 10.3389/Fnagi.2014.00154  0.667
2014 Wirth M, Villeneuve S, La Joie R, Marks SM, Jagust WJ. Gene-environment interactions: lifetime cognitive activity, APOE genotype, and β-amyloid burden. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 8612-7. PMID 24948815 DOI: 10.1523/Jneurosci.4612-13.2014  0.64
2014 Villeneuve S, Reed BR, Madison CM, Wirth M, Marchant NL, Kriger S, Mack WJ, Sanossian N, DeCarli C, Chui HC, Weiner MW, Jagust WJ. Vascular risk and Aβ interact to reduce cortical thickness in AD vulnerable brain regions. Neurology. 83: 40-7. PMID 24907234 DOI: 10.1212/Wnl.0000000000000550  0.724
2014 Wirth M, Haase CM, Villeneuve S, Vogel J, Jagust WJ. Neuroprotective pathways: lifestyle activity, brain pathology, and cognition in cognitively normal older adults. Neurobiology of Aging. 35: 1873-82. PMID 24656834 DOI: 10.1016/J.Neurobiolaging.2014.02.015  0.639
2014 Villeneuve S, Reed BR, Wirth M, Haase CM, Madison CM, Ayakta N, Mack W, Mungas D, Chui HC, DeCarli C, Weiner MW, Jagust WJ. Cortical thickness mediates the effect of β-amyloid on episodic memory. Neurology. 82: 761-7. PMID 24489134 DOI: 10.1212/Wnl.0000000000000170  0.531
2014 Reed B, Villeneuve S, Mack W, DeCarli C, Chui HC, Jagust W. Associations between serum cholesterol levels and cerebral amyloidosis. Jama Neurology. 71: 195-200. PMID 24378418 DOI: 10.1001/Jamaneurol.2013.5390  0.501
2014 Peters F, Villeneuve S, Belleville S. Predicting progression to dementia in elderly subjects with mild cognitive impairment using both cognitive and neuroimaging predictors. Journal of Alzheimer's Disease : Jad. 38: 307-18. PMID 23963293 DOI: 10.3233/Jad-130842  0.651
2014 Oh H, Madison C, Villeneuve S, Markley C, Jagust WJ. Association of gray matter atrophy with age, β-amyloid, and cognition in aging. Cerebral Cortex (New York, N.Y. : 1991). 24: 1609-18. PMID 23389995 DOI: 10.1093/Cercor/Bht017  0.779
2014 DeCarli C, Mungas D, Carmichael OT, Villeneuve S, Fletcher E, Singh B, Jagust W, Reed B. P2-075: VASCULAR RISK FACTORS IMPACT COGNITION INDEPENDENT OF PIB PET AND MRI MEASURES OF AD AND VASCULAR BRAIN INJURY Alzheimer's & Dementia. 10: P497-P498. DOI: 10.1016/j.jalz.2014.05.749  0.356
2014 Rabinovici GD, Cohn-Sheehy BI, Reed B, Villeneuve S, Ghosh PM, Madison C, Lehmann M, Olichney J, DeCarli CS, Miller BL, Borys E, Grinberg LT, Jin L, Seeley WW, Jagust WJ. IC-P-011: COMPARING LIBERAL AND CONSERVATIVE THRESHOLDS FOR AMYLOID PET POSITIVITY IN AUTOPSY-PROVEN CASES Alzheimer's & Dementia. 10: P12-P13. DOI: 10.1016/J.Jalz.2014.05.015  0.452
2014 Wirth M, Villeneuve S, La Joie R, Marks SM, Jagust WJ. O3-10-02: LIFETIME COGNITIVE ACTIVITY, APOLIPOPROTEIN E GENOTYPE, AND BRAIN BETA-AMYLOID Alzheimer's & Dementia. 10: P228-P228. DOI: 10.1016/J.Jalz.2014.04.324  0.534
2014 Villeneuve S, Madison C, Ayakta N, La Joie R, Cohn-Sheehy BI, Vogel J, Marks S, Arthur-Bentil SK, Reed B, DeCarli C, Rabinovici GD, Jagust W. IC-02-03: EXISTING THRESHOLDS FOR PIB POSITIVITY ARE TOO HIGH Alzheimer's & Dementia. 10: P4-P5. DOI: 10.1016/J.Jalz.2014.04.026  0.384
2014 DeCarli C, Mungas D, Carmichael OT, Villeneuve S, Fletcher E, Singh B, Jagust W, Reed B. IC-01-04: VASCULAR RISK FACTORS IMPACT COGNITION INDEPENDENT OF PIB PET AND MRI MEASURES OF AD AND VASCULAR BRAIN INJURY Alzheimer's & Dementia. 10: P2-P3. DOI: 10.1016/J.Jalz.2014.04.021  0.57
2013 He BJ, Nolte G, Nagata K, Takano D, Yamazaki T, Fujimaki Y, Maeda T, Satoh Y, Heckers S, George MS, Lopes da Silva F, de Munck JC, Van Houdt PJ, Verdaasdonk RM, Ossenblok P, ... ... Villeneuve S, et al. Abstracts of Presentations at the International Conference on Basic and Clinical Multimodal Imaging (BaCI), a Joint Conference of the International Society for Neuroimaging in Psychiatry (ISNIP), the International Society for Functional Source Imaging (ISFSI), the International Society for Bioelectromagnetism (ISBEM), the International Society for Brain Electromagnetic Topography (ISBET), and the EEG and Clinical Neuroscience Society (ECNS), in Geneva, Switzerland, September 5-8, 2013. Clinical Eeg and Neuroscience. PMID 24368763 DOI: 10.1177/1550059413507209  0.315
2013 Wirth M, Villeneuve S, Haase CM, Madison CM, Oh H, Landau SM, Rabinovici GD, Jagust WJ. Associations between Alzheimer disease biomarkers, neurodegeneration, and cognition in cognitively normal older people. Jama Neurology. 70: 1512-9. PMID 24166579 DOI: 10.1001/Jamaneurol.2013.4013  0.812
2013 Chao LL, Decarli C, Kriger S, Truran D, Zhang Y, Laxamana J, Villeneuve S, Jagust WJ, Sanossian N, Mack WJ, Chui HC, Weiner MW. Associations between white matter hyperintensities and β amyloid on integrity of projection, association, and limbic fiber tracts measured with diffusion tensor MRI. Plos One. 8: e65175. PMID 23762308 DOI: 10.1371/Journal.Pone.0065175  0.531
2013 Wirth M, Haase CM, Villeneuve S, Madison C, Oh H, Jagust W. P2-131: Relationships between cognitive activity, Alzheimer's disease pathological biomarkers and cognitive functioning in normal older adults Alzheimer's & Dementia. 9: P393-P394. DOI: 10.1016/J.Jalz.2013.05.775  0.77
2013 Villeneuve S, Reed B, Madison C, Wirth M, Kriger S, Haase CM, Marchant N, Decarli CS, Chui H, Weiner M, Jagust W. P1-319: The impact of beta-amyloid deposition and vascular risk factors on cortical thickness and cognition Alzheimer's & Dementia. 9: P274-P275. DOI: 10.1016/j.jalz.2013.05.545  0.323
2013 Villeneuve S, Reed B, Madison C, Wirth M, Kriger S, Haase CM, Marchant N, DeCarli CS, Chui H, Weiner M, Jagust W. IC-P-022: The impact of beta-amyloid deposition and vascular risk factors on cortical thickness and cognition Alzheimer's & Dementia. 9: P21-P22. DOI: 10.1016/J.Jalz.2013.05.023  0.545
2013 Oh H, Villeneuve S, Madison C, Vogel J, Jagust W. O4-09-05: Association of gray matter atrophy with age, beta-amyloid, white matter hyperintensity and cognition in normal aging Alzheimer's & Dementia. 9: P701-P702. DOI: 10.1016/J.Jalz.2013.04.387  0.727
2013 Wirth M, Tang G, Villeneuve S, Madison C, Oh H, Jagust W. O1-04-05: High-performing older adults: Cognitive and brain correlates Alzheimer's & Dementia. 9: P134-P134. DOI: 10.1016/J.Jalz.2013.04.071  0.531
2012 Villeneuve S, Pepin V, Rahayel S, Bertrand JA, de Lorimier M, Rizk A, Desjardins C, Parenteau S, Beaucage F, Joncas S, Monchi O, Gagnon JF. Mild cognitive impairment in moderate to severe COPD: a preliminary study. Chest. 142: 1516-23. PMID 23364388 DOI: 10.1378/Chest.11-3035  0.445
2012 Villeneuve S, Belleville S. The nature of memory failure in mild cognitive impairment: examining association with neurobiological markers and effect of progression. Neurobiology of Aging. 33: 1967-78. PMID 22088679 DOI: 10.1016/J.Neurobiolaging.2011.10.004  0.624
2011 Villeneuve S, Massoud F, Bocti C, Gauthier S, Belleville S. The nature of episodic memory deficits in MCI with and without vascular burden. Neuropsychologia. 49: 3027-35. PMID 21763333 DOI: 10.1016/J.Neuropsychologia.2011.07.001  0.577
2011 Hudon C, Villeneuve S, Belleville S. The effect of semantic orientation at encoding on free-recall performance in amnestic mild cognitive impairment and probable Alzheimer's disease. Journal of Clinical and Experimental Neuropsychology. 33: 631-8. PMID 21644138 DOI: 10.1080/13803395.2010.547663  0.637
2011 Villeneuve S, Rodrigues-Brazète J, Joncas S, Postuma RB, Latreille V, Gagnon JF. Validity of the Mattis Dementia Rating Scale to detect mild cognitive impairment in Parkinson's disease and REM sleep behavior disorder. Dementia and Geriatric Cognitive Disorders. 31: 210-7. PMID 21474929 DOI: 10.1159/000326212  0.391
2011 Villeneuve S, Pépin V, Rahayel S, Delorimier M, Bertrand J, Desjardins C, Gagnon J. P1-483: Mild cognitive impairment in chronic obstructive pulmonary disease Alzheimer's & Dementia. 7: S268-S268. DOI: 10.1016/J.Jalz.2011.05.765  0.404
2011 Villeneuve S, Belleville S. P1-482: The nature of memory failure in mild cognitive impairment: examining effect of progression and comorbid factors Alzheimer's & Dementia. 7: S267-S268. DOI: 10.1016/J.Jalz.2011.05.764  0.603
2010 Villeneuve S, Belleville S. [Cognitive reserve and neuronal changes associated with aging]. Psychologie & Neuropsychiatrie Du Vieillissement. 8: 133-40. PMID 20525544 DOI: 10.1684/Pnv.2010.0214  0.632
2010 Belleville S, Villeneuve S, Peters F, Protat S. Fardeau vasculaire, cognition et vieillissement Revue De Neuropsychologie. 2: 106-113. DOI: 10.1684/Nrp.2010.0065  0.492
2009 Villeneuve S, Belleville S, Massoud F, Bocti C, Gauthier S. Impact of vascular risk factors and diseases on cognition in persons with mild cognitive impairment. Dementia and Geriatric Cognitive Disorders. 27: 375-81. PMID 19321941 DOI: 10.1159/000209965  0.631
2009 Villeneuve S, Belleville S, Lacombe J, Labelle M, Enriquez-Rosas A, Gauthier S. Episodic memory deficits in vascular and non vascular mild cognitive impairment Journal of the Neurological Sciences. 283: 291. DOI: 10.1016/J.Jns.2009.02.196  0.588
2006 McSweeney M, Binette AP, Meyer P, Gonneaud J, Bedetti C, Ozlen H, Daoust L, Labonte A, Poirier J, Rosa-Neto P, Breitner JC, Villeneuve S. IC-P-209: EARLY INCREASE IN TAU-PET SIGNAL IS ASSOCIATED WITH Aβ BURDEN, CSF P-TAU LEVELS AND COGNITION IN COGNITIVELY NORMAL LATE-MIDDLE-AGED ADULTS Alzheimer's & Dementia. 14: P172-P173. DOI: 10.1016/J.Jalz.2018.06.2276  0.409
Show low-probability matches.